T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 4, 2000, Pages 287-294

  Altfeld, Marcus ^a,b   Addo, Marylyn Martina ^a   Kreuzer, Karl Anton ^a   Rockstroh, Jürgen Kurt ^a   Dumoulin, Franz Ludwig ^a   Schliefer, Kirsten ^a   Leifeld, Ludger ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytokines; HIV; RT PCR

Indexed keywords

BETA ACTIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0034177727     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200004010-00001     Document Type: Article

References (30)

1. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV-infections: cytokine induction of HIV expression. Immunol Today 1990;11:176-80.
2. Baiter M. AIDS research: cytokines move from the margins into the spotlight. Science 1995;268:205-6.
3. Hittinger G, Poggi C, Delbeke E, Profizi N, Lafeuillade A. Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients. Infection 1998;26:100-3.
4. Belec L, Meillet D, Hernvann A, Grésenguet G, Gherardi R. Differential elevation of circulating IL-1β, TNF-a and IL-6 in AIDS associated cachectic states. Clin Diagn Lab Immunol 1994;1:117-20.
5. Salazar-Gonzales JF, Martinez-Maza O, et al. Relationship of plasma HIV-RNA levels and levels of TNF-a and immune activation products in HIV infection. Clin Immunol Immunopathol 1997:84:36-45.
6. Clerici M, Balotta C, Meroni L, et al. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term non-progression in HIV infection. AIDS Res Hum Retroviruses 1996; 12:1053-61.
7. H2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8:757-62.
8. Canaris AD, Caruso A, Licenziati S, et al. Lack of polarised type 1 or type 2 cytokine profile in asymptomatic HIV-1 infected patients during a two-year bimonthly follow-up. Scand J Immunol 1998:47:146-51.
9. Fakoya A, Matear PM, Filley E, et al. HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state. AIDS 1997:11:1445-52.
10. Alonso K, Pontiggia P, Medenica R, Rizzo S. Cytokine patterns in adults with AIDS. Immunol Invest 1997:26:341-50.
11. Kreutzer K-A, Rockstroh JK, Sauerbruch T, Spengler U. A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-α. J Immunol Methods 1996:195:49-54.
12. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that effect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999;6:89-95.
13. Chehimi J, Ma X, Chouaib S, et a;. Differential production of Interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1996:12:1141-9.
14. Fan J, Nishanian P, Breen EC, McDonalds M, Fahey JL. Cytokine gene expression in normal lymphocytes in response to stimulation. Clin Diagn Lab Immunol 1998;5:335-40.
15. Diaz-Mitoma F, Kumar A, Karimi S, et al. Expression of IL-10, IL-4 and IFN-τ in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin Exp Immunol 1995:102:31-9.
16. H2 predominance in HIV-infected individuals. Science 1994;265:248-52.
17. Rieckmann P, Albrecht M, Ehrenreich H, Weber T, Michel U. Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med 1995;195:17-29.
18. Platzer C, Ode-Hakim S, Reinke P, Döcke WD, Ewert R, Volk HD. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 1994:58:264-8.
19. Dumoulin FL, Bach A, Leifeld L, et al. Semiquantitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis 1997;175:681-5.
20. Fauci AS, Schnittman SM, Poli GP, Koening S, Pantaleo G. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:678-93.
21. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV-infection: is AIDS a tumor necrosis factor disease? AIDS 1991;5: 1405-17.
22. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232:977-80.
23. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990;171:465-75.
24. Raab T, Bukrinsky M, Currie RA. Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide. J Biol Chem 1998;273:974-80.
25. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. Kappa B-Type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the TNF-α gene in primary macrophages. J Exp Med 1990;171:35-47.
26. Viganò A, Principi N, Villa ML, et al. Immunologic characterisation of children vertically infected with HIV, with slow or rapid disease progression. J Pediatr 1995;126:368-74.
27. + cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 1995;92:11135-9.
28. Barcellini W, Rizzardi GP, Velati C, et al. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS 1995; 9:691-4.
29. Clerici M, Shearer M. A Th1 → Th2 switch is a critical step in the etiology of HIV infection, Immunol Today 1993:14:107-11.
30. Kreuzer K-A, Dayer J-M, Rockstroh JK, Spengler U. The interleukin-1 system in HIV infection: peripheral concentrations of interleukin-1 beta, interleukin-1 receptor antagonist and soluble interleukin-1 receptor type II. Clin Exp Immunol 1997;109:54-8.